These findings underscore the synergistic role of furin and TMPRSS2 in facilitating viral entry and infection, suggesting that a combination of furin and TMPRSS2 inhibitors could serve as a powerful antiviral strategy against SARS-CoV-2. This evidence concerns the gene TMPRSS2 and infection.